MAPT and Parkinson disease: On a genetic level, studies in clinically defined PD have suggested that genotypes at the MAPT and SNCA loci act synergistically to confer susceptibility to PD and that variation at MAPT may be particularly associated with cognitive decline (Goris et al., 2007; Williams-Gray et al., 2009).